CompletedPhase 1NCT00005602
Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas
Studying Glial tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Roger J. Packer, MD, MDChildren's National Research Institute
- Intervention
- carboplatin(drug)
- Enrollment
- 13 target
- Eligibility
- 3-21 years · All sexes
- Timeline
- 2001 – 2005
Study locations (19)
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Indiana University Cancer Center, Indianapolis, Indiana, United States
- MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Mayo Clinic Cancer Center, Rochester, Minnesota, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- Herbert Irving Comprehensive Cancer Center, New York, New York, United States
- State University of New York - Upstate Medical University, Syracuse, New York, United States
- Albert Einstein Clinical Cancer Center, The Bronx, New York, United States
- Children's Hospital Medical Center - Cincinnati, Cincinnati, Ohio, United States
- Doernbecher Children's Hospital, Portland, Oregon, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- +4 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00005602 on ClinicalTrials.govOther trials for Glial tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07210632Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)Eben Rosenthal
- RECRUITINGNCT07236840Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain TumorsTata Memorial Centre
- RECRUITINGNCT07240662Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse GliomaiOMEDICO AG
- RECRUITINGNCT07405372Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of GliomasDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGPHASE2NCT07110246Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade GliomasUniversity of California, San Francisco
- RECRUITINGPHASE1NCT07223034A Study of 177Lu-PSMA-617 in People With GliomasMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGNCT07238322[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related ChangesTelix Pharmaceuticals (Innovations) Pty Limited
- RECRUITINGNANCT06397560PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies TrialBaptist Health South Florida